SCHEMBL23309546

SCHEMBL23309546

O=C(Nc1cc(Cl)c(Cl)c(Cl)c1)c1cc(F)nc(F)c1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 5/20 0.50
▸ ATF1 P18846 3/20 0.50
▸ JUN P05412 3/20 0.39
▸ NFKB2 Q00653 3/20 0.39
▸ RELA Q04206 3/20 0.39
▸ XPO1 O14980 3/20 0.39
▸ NPY1R P25929 1/20 0.38
▸ NPY2R P49146 1/20 0.38
▸ NPC1 O15118 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ FADS1 O60427 2/20 0.38
▸ P2RX1 P51575 2/20 0.38
▸ P2RX4 Q99571 2/20 0.38
▸ P2RX7 Q99572 2/20 0.38
▸ DHODH Q02127 1/20 0.38
▸ TMPRSS4 Q9NRS4 1/20 0.37
▸ ENPP2 Q13822 2/20 0.37
▸ LPAR1 Q92633 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309502 0.88 NFKB1 (0.51) NFKB1ATF1JUNNFKB2RELA
SCHEMBL23309495 0.85 FADS1 (0.56) NPC1RAB9AFADS1MAPTKDM4E
SCHEMBL23309730 0.83 KMT2A (0.47) NPC1RAB9AP2RX1MAPTKDM4E
SCHEMBL23309539 0.82 NPC1 (0.52) NPY1RNPY2RNPC1RAB9AMAPT
SCHEMBL23309708 0.82 RAB9A (0.52) NPC1RAB9AP2RX1P2RX4P2RX7
SCHEMBL23309531 0.82 MAOB (0.49) NPY1RNPY2RNPC1RAB9AFADS1
SCHEMBL23309587 0.81 MAPT (0.47) NFKB1JUNNFKB2RELAP2RX1
SCHEMBL23309603 0.80 CYP1A2 (0.56) NPC1RAB9AKMT2A
SCHEMBL23309548 0.79 FADS1 (0.55) NPC1RAB9AFADS1P2RX1P2RX4
SCHEMBL23309490 0.79 GAA (0.51) NPC1RAB9AKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL NFKB1 487/4885ATF1 3188/4885JUN 3044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback